OS and time to AML progression in MDS patients. OS (A) and time to AML progression (B) in MDS patients according to SRSF2 mutation status (log-rank test) are shown. OS (C) and time to AML progression (D) in MDS patients according to U2AF1 mutation status (log-rank test) are shown.